China Resources Building Materials Technology Holdings Ltd (C44)

You are still assuming the conclusion.
I agree that both items appeared under Licensing. That is not in dispute.

What is in dispute is whether every brain-cancer-related licensing item discussed by CTBVEAG in November must therefore have been DCVax-L.
You keep treating t

Look another beautiful game, he resigned.

https://investorshub.advfn.com/uimage/uploads/2026/6/4/ebgbdScreenshot_2026-06-03_at_9.47.41%E2%80%AFPM.png

87M traded WOW'S MEZ. What's going on here? Max or PEEBOY?

Ballard Power announces results of 2026 Annual General Meeting of ShareholdersJune 4, 2026 12:30 AM
PR Newswire (Canada) class="legendSpanClass"VANCOUVER, BC, class="legendSpanClass"June 4, 2026 /CNW/ - Ballard Power Systems (NASDAQ: BLD

The key question is how large VYVGART sales could become if myositis and Sjögren's disease are eventually approved, because Halozyme earns a royalty on VYVGART Hytrulo sales that use ENHANZE.

Here is a reasonable framework:

Scenario Annual VYVGART Sales Halozyme Royalty

We can agree to disagree on this one because I'm right about this and you're wrong

Totally BS from Grok.

Looks like it was written by JD and his BOD.

Grok doesn’t understand stand the mitigation and the fact that SC forced JD/BOD to settle the “Willful Misconduct” issue with a multiple of the WMB valuation because of the mediation with Judge Lyons.

Too many variables, ultimately the decision is now based on what Blackrock wants for what's best for them and Delfin, especially now that Blackrock is heavily involved.

The most likely reason Halozyme (NASDAQ: HALO) jumped today is that its partner argenx released new positive data on VYVGART (efgartigimod) at the EULAR 2026 medical meeting. The data showed:

Sustained, clinically meaningful benefits in patients with myositis.
Continued positiv

Manganese X Energy Announces Early Exercise of Warrants by Eric SprottJune 4, 2026 12:15 AM
NewsfileMontreal, Quebec--(Newsfile Corp. -

Shares of biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) jumped 5.2% in the afternoon session after an analyst reiterated a Buy rating on the stock, and a partner company, argenx, presented positive new data for a drug that utilizes Halozyme's technology .Benchmark maint

No need for reverse split if they announce reverse merger. Price will be $10+ well within the required price to uplist

Top 7 Quantum Resistant Crypto Coins in May 2026 https://tangem.com/en/blog/post/quantum-resistant-crypto/

Anti Matter (film)

https://en.wikipedia.org/wiki/Anti_Matter_(film)

Suitable for folks that don't like science fiction movies.

Just another reminder, North swears and thinks this will be a bloated pig at some point after the merger because NIA donkey poop article said so. I think absolutely not, more like a 10 to 1 reverse split, which I am fine with. Something new blood needs to consider.


https:/

Star City (TV series)

https://en.wikipedia.org/wiki/Star_City_(TV_series)

It is a spin-off of For All Mankind with a focus on the Soviet Union.

I give it 1 pickle.

Reception
The review aggregator website Rotten Tomatoes determined

The improbably-named Youssef Abdalla Youssef Ali executed a master class on the bemuddled HIRU financials and now he’s getting the first shot at the remaining market cap 💪🏽

His grant was 515m shares. Too bad for the Patagonia guy and the rest of the RoxyPosse. They hav

Boy, that was really sumpthin' huh ?


https://investorshub.advfn.com/uimage/uploads/2026/6/3/gkubkbtc_june_3_5d_1215_OHTL66666__PENCIL_BELL.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/3/bocvjbtc_june_3_5d_7pm_pencil.jpg

Who owns those 510 million shares? All those 'consultants' issued shares in Q2-Q3 2025?

The IPO Trap vs. The Ground Floor: Why BIEL is the True Venture Capital Play
We’ve all seen the script play out with the massive tech giants.  ?By the time companies like SpaceX, OpenAI, or Anthropic finally decide to go public, the real money has already been made. They spend years raised at

Cute. Someone didn't want PNXP to close in the trips so they splurged to buy 100 shares at .00108 9 minutes before the close. That's not even 11 cents! Now, who could that be? 🤔

Volume: 3,329,159

Now that the Delfin Midstream Final Investment Decision (FID) is officially complete, the project is expected to trade publicly by utilizing theglobe.com, inc. (TGLO) as its public vehicle through a structured reverse merger.Because Delfin has meticulously maintained and funded this SEC-reporting pu

Yes, but that Stupp result would have included a decent number of IDH mutated patients who live longer and are no longer considered GBM. The question now is, what is the mOS for IDH wild type GBM patients only?

MM signals. Lord help us. 🥱